George Golumbeski serves as Senior Vice President of Business Development for Celgene Corporation, where he is responsible for developing collaborations with biotechnology companies which seek to bring "step-ahead" medications to patients suffering from cancer and/or chronic inflammation. In his 25-year career in this sector, George has worked in many therapeutic areas, including CNS, CV, ID, Oncology, and Chronic Inflammation. He is known within the biotechnology industry for his interest in leading-edge science, and his constructiveness in creating inter-company collaborations.
George currently serves on the Board of Directors/Trustees of Acceleron Pharma (Cambridge, MA) and Enanta Pharmaceuticals (Watertown, MA). He received a BA in Biology from the University of Virginia, a PhD in Genetics from the University of Wisconsin-Madison, and conducted his post-doctoral research in molecular biology at the University of Colorado-Boulder.